{"id":"W4411994968","doi":"10.1182/blood.2024027468","title":"Marstacimab prophylaxis in hemophilia A/B without inhibitors: results from the phase 3 BASIS trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Grifols; Regeneron Pharmaceuticals; Novo Nordisk; Sanofi; Chugai Pharmaceutical; Amgen; Pfizer; Swedish Orphan Biovitrum; BioMarin Pharmaceutical; CSL Behring; F. Hoffmann-La Roche","keywords":"Medicine; Factor IX; Hemostasis; Internal medicine; Clinical trial; Clinical endpoint; Phases of clinical research; Gastroenterology; Adverse effect; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002149027,0.0005811672,0.001293386,0.0001296745,0.0002129054,0.0008885437,0.0004591553,0.0006579402,0.003256542],"category_scores_gemma":[0.001972099,0.0001515973,0.001372944,0.0002782007,0.0003094365,0.0005040379,0.0002771066,0.001582742,0.0004609718],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003497314,"about_ca_system_score_gemma":0.0007646676,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004333044,"about_ca_topic_score_gemma":0.0008431817,"domain_scores_codex":[0.9991714,0.0005645094,0.00003992968,0.00006402775,0.0000841356,0.00007608401],"domain_scores_gemma":[0.998909,0.000332636,0.0003693685,0.000104469,0.00008641455,0.000198085],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8254786,0.005354791,0.01034774,0.002133867,0.005265618,0.0002261033,0.0001631434,0.001125149,0.007455048,0.0004543748,0.01133364,0.1306619],"study_design_scores_gemma":[0.7976085,0.1246067,0.05963863,0.0004008744,0.004634182,0.0009936242,0.0001115016,0.001971641,0.002312015,0.0007314988,0.006917255,0.00007358361],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9779874,0.01568359,0.0004300992,0.0008683922,0.0001396026,0.0004301792,0.001444505,0.00009188829,0.002924446],"genre_scores_gemma":[0.989989,0.00489841,0.0008434014,0.0006729818,0.0001891514,0.0005138069,0.001927923,0.00002201091,0.0009432384],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003256542,"threshold_uncertainty_score":0.01136529,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02719290802489917,"score_gpt":0.3274449486869177,"score_spread":0.3002520406620185,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}